1. Home
  2. SSSS vs RENB Comparison

SSSS vs RENB Comparison

Compare SSSS & RENB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SSSS
  • RENB
  • Stock Information
  • Founded
  • SSSS 2010
  • RENB 2011
  • Country
  • SSSS United States
  • RENB United States
  • Employees
  • SSSS N/A
  • RENB N/A
  • Industry
  • SSSS Finance: Consumer Services
  • RENB Biotechnology: Pharmaceutical Preparations
  • Sector
  • SSSS Finance
  • RENB Health Care
  • Exchange
  • SSSS Nasdaq
  • RENB Nasdaq
  • Market Cap
  • SSSS 138.2M
  • RENB 57.7M
  • IPO Year
  • SSSS N/A
  • RENB N/A
  • Fundamental
  • Price
  • SSSS $9.21
  • RENB $0.16
  • Analyst Decision
  • SSSS Strong Buy
  • RENB
  • Analyst Count
  • SSSS 4
  • RENB 0
  • Target Price
  • SSSS $9.50
  • RENB N/A
  • AVG Volume (30 Days)
  • SSSS 166.9K
  • RENB 1.2M
  • Earning Date
  • SSSS 11-06-2025
  • RENB 11-13-2025
  • Dividend Yield
  • SSSS 10.90%
  • RENB N/A
  • EPS Growth
  • SSSS N/A
  • RENB N/A
  • EPS
  • SSSS 2.22
  • RENB N/A
  • Revenue
  • SSSS $2,784,381.00
  • RENB N/A
  • Revenue This Year
  • SSSS $7,183.09
  • RENB N/A
  • Revenue Next Year
  • SSSS N/A
  • RENB N/A
  • P/E Ratio
  • SSSS $4.13
  • RENB N/A
  • Revenue Growth
  • SSSS N/A
  • RENB N/A
  • 52 Week Low
  • SSSS $3.77
  • RENB $0.16
  • 52 Week High
  • SSSS $9.50
  • RENB $2.10
  • Technical
  • Relative Strength Index (RSI)
  • SSSS 67.20
  • RENB 29.75
  • Support Level
  • SSSS $8.99
  • RENB $0.18
  • Resistance Level
  • SSSS $9.50
  • RENB $0.22
  • Average True Range (ATR)
  • SSSS 0.19
  • RENB 0.02
  • MACD
  • SSSS 0.04
  • RENB -0.00
  • Stochastic Oscillator
  • SSSS 67.78
  • RENB 1.54

About SSSS SuRo Capital Corp.

SuRo Capital Corp is a non-diversified closed-end management investment company. The company's investment objective is to maximize its portfolio's total return, principally by seeking capital gains on its equity and equity-related investments.

About RENB Renovaro Biosciences Inc.

Renovaro Inc is a biopharmaceutical company. It is engaged in developing new immunotherapies to combat cancer and developing a predicative artificial intelligence-based diagnostic methodology for the use of earlier cancer detection.

Share on Social Networks: